Drug Trial Radar · NCT00342381
Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Last checked: Nov 20, 2026Latest source record: Dec 17, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Planned (sponsor's estimate)
Start
Jun 2006
Primary completion
Not stated
Study completion Dec 2007
Sponsor
- Lead sponsor
- University of AarhusAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Danish Multiple Sclerosis Society
- First posted
- Jun 21, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate fatigue in patients with multiple sclerosis (MS) and to determine the correlation between the symptom and cerebral changes.
Conditions
- Multiple Sclerosis
- Fatigue
Interventions
3,4-diaminopyridineDrug
Single dose 3,4 diaminopyridine
PlaceboDrug
Single dose placebo treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjective fatigue (FSS)Time frame: Weeks
- Maximal voluntary isometric contraction, central activation before and after exerciseTime frame: at the time of investigation
- Digit Symbol-Coding scoresTime frame: Weeks
- Changes in normal appearing white matter and normal appearing gray matter (MRS-, MTI- and DTI- parameters)Time frame: at the time of MRI
- Cortical atrophyTime frame: at the time of MRI
- Intracortical inhibition/facilitation determined by transcranial magnetic stimulation (+/- 3,4-diaminopyridine)Time frame: at the time of investigation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aarhus University Hospital, Department of Neurology
Aarhus, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.